These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26139125)

  • 21. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary studies of
    Lahooti A; Shanehsazzadeh S; Laurent S
    Nanotechnology; 2020 Jan; 31(1):015102. PubMed ID: 31519003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Testing of Modular Dual-Modality Nanoparticles for Magnetic Resonance and Multispectral Photoacoustic Imaging.
    Bogdanov AA; Dixon AJ; Gupta S; Zhang L; Zheng S; Shazeeb MS; Zhang S; Klibanov AL
    Bioconjug Chem; 2016 Feb; 27(2):383-90. PubMed ID: 26603129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
    Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
    Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
    Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
    Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative positron emission tomography imaging of angiogenesis in rats with forelimb ischemia using (68)Ga-NOTA-c(RGDyK).
    Kim JH; Kim YH; Kim YJ; Yang BY; Jeong JM; Youn H; Lee DS; Lee JS
    Angiogenesis; 2013 Oct; 16(4):837-46. PubMed ID: 23857293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystems.
    Tombácz E; Turcu R; Socoliuc V; Vékás L
    Biochem Biophys Res Commun; 2015 Dec; 468(3):442-53. PubMed ID: 26275707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
    Tzameret A; Ketter-Katz H; Edelshtain V; Sher I; Corem-Salkmon E; Levy I; Last D; Guez D; Mardor Y; Margel S; Rotenstrich Y
    J Nanobiotechnology; 2019 Jan; 17(1):3. PubMed ID: 30630490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle.
    Kim SM; Chae MK; Yim MS; Jeong IH; Cho J; Lee C; Ryu EK
    Biomaterials; 2013 Nov; 34(33):8114-21. PubMed ID: 23932293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
    J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiolabeled ultra-small Fe
    Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
    Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Semiconducting Perylene Diimide Nanoparticle Size on Lymph Node Mapping and Cancer Imaging.
    Yang Z; Tian R; Wu J; Fan Q; Yung BC; Niu G; Jacobson O; Wang Z; Liu G; Yu G; Huang W; Song J; Chen X
    ACS Nano; 2017 Apr; 11(4):4247-4255. PubMed ID: 28345873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
    Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular platform for design and synthesis of targeted dual-modality imaging probes.
    Kumar A; Zhang S; Hao G; Hassan G; Ramezani S; Sagiyama K; Lo ST; Takahashi M; Sherry AD; Öz OK; Kovacs Z; Sun X
    Bioconjug Chem; 2015 Mar; 26(3):549-58. PubMed ID: 25615011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.
    Nordmeyer D; Stumpf P; Gröger D; Hofmann A; Enders S; Riese SB; Dernedde J; Taupitz M; Rauch U; Haag R; Rühl E; Graf C
    Nanoscale; 2014 Aug; 6(16):9646-54. PubMed ID: 24991655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.
    Sharma VK; Alipour A; Soran-Erdem Z; Aykut ZG; Demir HV
    Nanoscale; 2015 Jun; 7(23):10519-26. PubMed ID: 26010145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
    Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G
    Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent.
    Torres Martin de Rosales R; Tavaré R; Paul RL; Jauregui-Osoro M; Protti A; Glaria A; Varma G; Szanda I; Blower PJ
    Angew Chem Int Ed Engl; 2011 Jun; 50(24):5509-13. PubMed ID: 21544908
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnetic resonance imaging of post-ischemic blood-brain barrier damage with PEGylated iron oxide nanoparticles.
    Liu DF; Qian C; An YL; Chang D; Ju SH; Teng GJ
    Nanoscale; 2014 Dec; 6(24):15161-7. PubMed ID: 25374303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.